Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - CRBP

Basics
Company: Corbus Pharmaceuticals Holdings, Inc. Common Stock
IPO Date: November 1, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $103.65M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.31 | 3.90%
Avg Daily Range (30 D): $0.44 | 4.01%
Avg Daily Range (90 D): $0.45 | 3.11%
Institutional Daily Volume
Avg Daily Volume: .1M
Avg Daily Volume (30 D): .22M
Avg Daily Volume (90 D): .27M
Trade Size
Avg Trade Size (Sh.): 20
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 66
Institutional Trades
Total Inst.Trades: 429
Avg Inst. Trade: $1.77M
Avg Inst. Trade (30 D): $1.13M
Avg Inst. Trade (90 D): $1.2M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.06M
Avg Closing Trade (30 D): $7.3M
Avg Closing Trade (90 D): $1.06M
Avg Closing Volume: 39.34K
   
News
Jun 1, 2024 @ 2:00 PM
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targe...
Source: Corbus Pharmaceuticals Holdings, Inc.
May 23, 2024 @ 9:05 PM
Updated Phase 1 Clinical Data for SYS-6002 (CRB-70...
Source: Corbus Pharmaceuticals Holdings, Inc.
May 14, 2024 @ 5:32 PM
Will Pharma And Healthcare Have Competitive Edge I...
Source: Nicolás Jose Rodriguez
Apr 24, 2024 @ 8:05 PM
Corbus Pharmaceuticals Announces Abstract Accepted...
Source: Corbus Pharmaceuticals Holdings, Inc.
Apr 16, 2024 @ 12:50 PM
Here's What Could Help Corbus Pharmaceuticals (CRB...
Source: Zacks Equity Research
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-4.69 $-1.15 $-.9
Diluted EPS $-4.71 $-1.15 $-.9
Revenue $ -1.72M $ 1.19M $ .91M
Gross Profit $ $ $
Net Income / Loss $ -38.7M $ -13.78M $ -10M
Operating Income / Loss $ -46.22M $ -15.51M $ -10.99M
Cost of Revenue $ $ $
Net Cash Flow $ 8.17M $ -4.26M $ 9.58M
PE Ratio    
Splits
Feb 14, 2023:   30:1